Statera BioPharma (STAB) Q3 2022 Earnings Report
STAB Q3 2022 EPS Results
- Actual EPS
- -$0.07
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -$0.47
STAB Q3 2022 Revenue Results
- Actual Revenue
- $670.47K
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +183.48%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 11/14/2022
- Time
- TBA
- Conference Call
- Monday, November 14, 2022
Q3 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
STAB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Aug 14, 2023 | 2023 (Q2) | ―- | ― | ― | |
| Nov 14, 2022 | 2022 (Q3) | ―-0.07 | -0.47 | 85.74% (+0.40) | |
| Aug 15, 2022 | 2022 (Q2) | ―- | -0.04 | ― | |
| Nov 15, 2021 | 2021 (Q3) | ―-0.47 | -0.06 | -724.56% (-0.41) | |
| Aug 16, 2021 | 2021 (Q2) | ―-0.04 | -0.03 | -38.71% (-0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed